9-Jul-2026 - Insider Monkey Truist Raises its Price Target on Amgen (AMGN) On July 7, 2026, Truist raised the firm’s price target on Amgen Inc. (NASDAQ:AMGN) to $340 from $327 as part of a broader Q2 ...
8-Jul-2026 - StockStory.org Amgen (AMGN): Buy, sell, or hold post Q1 earnings? Amgen trades at $365.22 per share and has stayed right on track with the overall market, gaining 12% over the last six months ...
7-Jul-2026 - Yahoo Finance Amgen (AMGN) Recalls Sensipar And Corlanor In Broad US Quality Sweep Amgen has initiated several product recalls in the US for Sensipar (cinacalcet) and Corlanor (ivabradine). The recalls involve multiple lots, dosage strengths, and large product quantities distributed ...
2-Jul-2026 - Yahoo Finance Amgen (AMGN) Stock Is Up, What You Need To Know Shares of biotech company Amgen (NASDAQ:AMGN) jumped 3.1% in the afternoon session after the company received a favorable ...
1-Jul-2026 - Reuters Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel By Jonathan Stempel July 1 (Reuters) - A federal judge on Wednesday blocked Colorado from capping the price of Amgen's blockbuster arthritis drug Enbrel, a first-of-its-kind move by a U.S. state. In ...
1-Jul-2026 - Yahoo Finance Amgen or Biogen: Which Biotech Stock Appears Better Poised? AMGN stands out compared to Biogen given its broader product portfolio, pipeline depth and steadier growth outlook despite patent and competition risks.
Latest AMGN Trades by Congress Members
5-JUN-2026 - David J. Taylor, OH (District 2) purchased between $1,001 and $15,000.
9-Jul-2026 - Insider Monkey Truist Raises its Price Target on Amgen (AMGN) On July 7, 2026, Truist raised the firm’s price target on Amgen Inc. (NASDAQ:AMGN) to $340 from $327 as part of a broader Q2 ...
8-Jul-2026 - StockStory.org Amgen (AMGN): Buy, sell, or hold post Q1 earnings? Amgen trades at $365.22 per share and has stayed right on track with the overall market, gaining 12% over the last six months ...
7-Jul-2026 - Yahoo Finance Amgen (AMGN) Recalls Sensipar And Corlanor In Broad US Quality Sweep Amgen has initiated several product recalls in the US for Sensipar (cinacalcet) and Corlanor (ivabradine). The recalls involve multiple lots, dosage strengths, and large product quantities distributed ...
2-Jul-2026 - Yahoo Finance Amgen (AMGN) Stock Is Up, What You Need To Know Shares of biotech company Amgen (NASDAQ:AMGN) jumped 3.1% in the afternoon session after the company received a favorable ...
1-Jul-2026 - Reuters Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel By Jonathan Stempel July 1 (Reuters) - A federal judge on Wednesday blocked Colorado from capping the price of Amgen's blockbuster arthritis drug Enbrel, a first-of-its-kind move by a U.S. state. In ...
1-Jul-2026 - Yahoo Finance Amgen or Biogen: Which Biotech Stock Appears Better Poised? AMGN stands out compared to Biogen given its broader product portfolio, pipeline depth and steadier growth outlook despite patent and competition risks.
